Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Sinotecean in Advanced Cancer
NCT02469883Phase 1Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sinotecan in cancer, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Primary endpoints: Area Under Curve, Maximum Plasma Concentration and 1 more. Status: unknown.
02
Drugs
sinotecan
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02469883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469883.